Therapeutic Focus

Treatment of Cytokine Release Syndrome

RH Nanopharma is focused on reducing overactive immune responses in the human body. Therapy using salsalate both in nano and regular formulations for oral, topical gel, ocular suspension, and parenteral administration is our driving force. There is no safer therapeutic agent for reducing inflammation than is salsalate.